Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
83.7M
-
Number of holders
-
136
-
Total shares
-
44M
-
Shares change
-
+4.97M
-
Total reported value, excl. options
-
$1B
-
Value change
-
+$115M
-
Put/Call ratio
-
0.25
-
Number of buys
-
82
-
Number of sells
-
-51
-
Price
-
$22.76
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, $0.001 par value per share (STRO) as of Q1 2021
140 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, $0.001 par value per share as of Q1 2021.
SUTRO BIOPHARMA, INC. - Common Stock, $0.001 par value per share (STRO) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44M shares
of 83.7M outstanding shares and own 52.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.1M shares), FRANKLIN RESOURCES INC (2.65M shares), STATE STREET CORP (2.51M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.37M shares), RA CAPITAL MANAGEMENT, L.P. (2.12M shares), First Light Asset Management, LLC (2.06M shares), VANGUARD GROUP INC (2.04M shares), SV Health Investors, LLC (1.82M shares), BAILLIE GIFFORD & CO (1.7M shares), and Samsara BioCapital, LLC (1.68M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.